Magnija Sulfāts

Magnesium sulfate, the active ingredient in Magnija Sulfāts, is a magnesium compound presented as a sterile injectable solution for intramuscular and intravenous use. It replenishes magnesium ions, supporting enzymatic reactions, neuromuscular transmission and cardiac electrophysiology, and is employed in the management of magnesium deficiency and related acute clinical conditions. The product conforms to EU pharmacopeial standards and is indicated for emergency obstetric care, cardiac arrhythmias, severe asthma and other electrolyte disturbances.

GNH USA supplies Magnija Sulfāts as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Magnija Sulfāts acts on electrolyte balance and neuromuscular function, making it useful in several acute medical situations. - Magnesium deficiency: restores normal serum magnesium levels and prevents related neuromuscular symptoms. - Eclampsia and severe preeclampsia: prevents seizures by stabilising neuronal excitability. - Torsades de pointes and other ventricular arrhythmias: shortens QT interval and reduces arrhythmic risk. - Severe asthma exacerbations: relaxes bronchial smooth muscle to improve airflow. - Acute myocardial infarction (adjunct therapy): supports cardiac electrophysiology during reperfusion.

Adverse reactions may occur with intravenous or intramuscular administration.

Common Side Effects: - Flushing or warmth at the injection site - Sweating or feeling of heat - Nausea or mild gastrointestinal discomfort - Headache or dizziness - Transient hypotension - Muscle weakness or fatigue

Serious or Rare Side Effects: - Severe hypotension or cardiovascular collapse - Respiratory depression or apnea - Cardiac arrest or severe arrhythmias - Hypermagnesemia with neuromuscular blockade - Anaphylactic or severe allergic reaction - Tissue necrosis or ulceration at injection site

Use of Magnija Sulfāts requires careful clinical assessment and monitoring. - Renal impairment: monitor serum magnesium and adjust dosage to avoid accumulation. - Cardiac disease: observe ECG and blood pressure continuously during administration. - Pregnancy: safety category unknown; weigh potential benefits against risks before use. - Concomitant neuromuscular blockers: increased risk of prolonged paralysis; monitor neuromuscular function. - Administration: verify correct concentration and route (IV/IM) before injection. - Store below 25°C: keep in original container, protect from moisture and light.

Magnesium sulfate can affect the activity of several other medicines.

Major Interactions (Avoid): - Calcium‑containing solutions: may precipitate magnesium sulfate, reducing efficacy. - Neuromuscular blocking agents: potentiation can lead to prolonged paralysis. - High‑dose aminoglycosides: increased risk of neuromuscular blockade.

Moderate Interactions (Monitor Closely): - Loop diuretics: enhance renal magnesium loss; monitor serum levels. - ACE inhibitors or ARBs: additive effects on electrolyte balance; watch potassium. - Antacids containing aluminum or magnesium: may interfere with absorption (relevant for oral forms).